China National Accord Medicines Corporation Ltd. Logo

China National Accord Medicines Corporation Ltd.

SHE-000028
Shenzhen Stock Exchange NYSE
Healthcare Medical Distribution
Global Rank
#6419
Country Rank
n/a
Market Cap
1.83 B
Price
3.53
Change (%)
0.20%
Volume
1.29 M

China National Accord Medicines Corporation Ltd.'s latest marketcap:

1.83 B

As of 06/07/2025, China National Accord Medicines Corporation Ltd.'s market capitalization has reached $1.83 B. According to our data, China National Accord Medicines Corporation Ltd. is the 6419th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.83 B
Revenue (ttm) 10.23 B
Net Income (ttm) 80.86 M
Shares Out 556.57 M
EPS (ttm) 0.14
Forward PE 11.20
Ex-Dividend Date 06/25/2024
Earnings Date 08/29/2025
Market Cap Chart
Data Updated: 06/07/2025

China National Accord Medicines Corporation Ltd.'s yearly market capitalization.

China National Accord Medicines Corporation Ltd. has seen its market value drop from ¥18.13 B to ¥13.15 B since 2020, representing a total decrease of 27.48% and an annual compound decline rate (CAGR) of 6.99%.
Date Market Cap Change (%)
06/07/2025 ¥13.15 B -13.23%
12/31/2024 ¥15.15 B 1.45%
12/29/2023 ¥14.94 B 13.47%
12/30/2022 ¥13.16 B -10.48%
12/31/2021 ¥14.71 B -18.89%
12/31/2020 ¥18.13 B

Company Profile

About China National Accord Medicines Corporation Ltd.

China National Accord Medicines Corporation Ltd. is a leading pharmaceutical company specializing in the retail and distribution of medical products across China and internationally.

Core Business Activities

  • Pharmaceutical Distribution: Retail and wholesale of drugs, medical equipment, and health supplies.
  • Logistics & Warehousing: Cargo transportation, warehousing, and loading/unloading services.
  • Additional Services: Sales of cosmetics, daily necessities, and professional consulting services.
  • Import/Export Operations: Trade of proprietary Chinese medicines, chemical preparations, antibiotics, and diagnostic products.

Company Background

Originally established as Shenzhen Health Mineral Water Corp., Ltd. in 1993, the company rebranded and expanded its operations. Today, it operates as a subsidiary of Sinopharm Group Co., Ltd. and is headquartered in Shenzhen, China.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.